Company intelligence / Profile preview

TechCoire

Ownership: Private
Development stage: Other

Overview

TechCoire is an emerging biotechnology company focused on the intersection of advanced computational modeling and drug discovery. The company leverages its proprietary platform to identify novel therapeutic targets and optimize lead candidates across a range of therapeutic areas, including oncology and infectious diseases. By integrating high-throughput screening with predictive analytics, TechCoire aims to accelerate the development of next-generation small molecules and biologics. The company is currently advancing several pre-clinical programs while establishing strategic collaborations with academic and industry partners to expand its pipeline.

Therapeutic areas: OncologyInfectious Diseases
Modalities: Small moleculeBiologic
Industry: Biotech

Beyond the preview

Go deeper on TechCoire.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TechCoire.

Explore the full profile